TransAct Technologies Inc(TACT)Finding the best opportunities to buy and sell stocks daily.
TransAct Technologies Incorporated designs, develops, and markets transaction-based and specialty printers and terminals in the United States and internationally. Its thermal and inkjet printers and terminals to generates labels, coupons, and transaction records, such as receipts, tickets, and other documents, as well as printed logging and plotting of data. The company also provides consumable products, including inkjet cartridges, ribbons, receipt papers, color thermal papers, and other printing supplies, as well as replacement parts; maintenance, repair, and testing services; and refurbished printers. In addition, it offers EPICENTRAL print system, a software solution that enables casino operators to create promotional coupons and marketing messages, and print them at the slot machine; and technical support services, as well as spare parts and accessories. Further, the company provides BOHA! terminal for the food service technology solution market that combines hardware and software components in a device that includes an operating system, touchscreen, and one or two thermal print mechanisms. It markets its products under the BOHA!, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names for restaurant, point of sale automation and banking, casino and gaming, lottery, oil and gas, and hospitality markets, as well as government. The company sells its products to original equipment manufacturers, resellers, and distributors, as well as directly to end-users through online Webstore transactsupplies.com. TransAct Technologies Incorporated was founded in 1996 and is headquartered in Hamden, Connecticut.
All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.